You are viewing a version of a model that has been updated. To access the latest version, and a more detailed display please go here.

Proctor2010 - a link between GSK3 and p53 in Alzheimer's Disease

View the 2013-07 Model of the Month entry for this model
Model Identifier
BIOMD0000000286
Short description

This is the model described the article:
GSK3 and p53 - is there a link in Alzheimer's disease?
Carole J Proctor and Douglas A Gray Molecular Neurodegeneration 2010, 5:7; doi: 10.1186/1750-1326-5-7
Abstract:
Background: Recent evidence suggests that glycogen synthase kinase-3beta (GSK3beta) is implicated in both sporadic and familial forms of Alzheimer's disease. The transcription factor, p53 also plays a role and has been linked to an increase in tau hyperphosphorylation although the effect is indirect. There is also evidence that GSK3beta and p53 interact and that the activity of both proteins is increased as a result of this interaction. Under normal cellular conditions, p53 is kept at low levels by Mdm2 but when cells are stressed, p53 is stabilised and may then interact with GSK3beta. We propose that this interaction has an important contribution to cellular outcomes and to test this hypothesis we developed a stochastic simulation model.
Results: The model predicts that high levels of DNA damage leads to increased activity of p53 and GSK3beta and low levels of aggregation but if DNA damage is repaired, the aggregates are eventually cleared. The model also shows that over long periods of time, aggregates may start to form due to stochastic events leading to increased levels of ROS and damaged DNA. This is followed by increased activity of p53 and GSK3beta and a vicious cycle ensues.
Conclusions: Since p53 and GSK3beta are both involved in the apoptotic pathway, and GSK3beta overactivity leads to increased levels of plaques and tangles, our model might explain the link between protein aggregation and neuronal loss in neurodegeneration.


Notes: The original model submitted by the author had events in it. Since, this model is intended for Stochastic Simulation run and Copasi cannot handle events in Stochastic run, I have replaced the events with piecewise assignment rule. -Viji

This model is an extension of Proctor_p53_Mdm2_ATM ( BIOMD0000000188 ).

This model originates from BioModels Database: A Database of Annotated Published Models (http://www.ebi.ac.uk/biomodels/). It is copyright (c) 2005-2010 The BioModels.net Team.
For more information see the terms of use .
To cite BioModels Database, please use: Li C, Donizelli M, Rodriguez N, Dharuri H, Endler L, Chelliah V, Li L, He E, Henry A, Stefan MI, Snoep JL, Hucka M, Le Novère N, Laibe C (2010) BioModels Database: An enhanced, curated and annotated resource for published quantitative kinetic models. BMC Syst Biol., 4:92.

Format
SBML (L2V4)
Related Publication
  • GSK3 and p53 - is there a link in Alzheimer's disease?
  • Carole J Proctor, Douglas A Gray
  • Molecular neurodegeneration , 1/ 2010 , Volume 5 , pages: 7 , PubMed ID: 20181016
Contributors
Submitter of the first revision: Carole Proctor
Submitter of this revision: Carole Proctor
Curator: Lucian Smith
Modeller: Carole Proctor

Metadata information

is (2 statements)
BioModels Database BIOMD0000000286
BioModels Database MODEL0910130002

isDerivedFrom (3 statements)
BioModels Database BIOMD0000000105
BioModels Database BIOMD0000000188
BioModels Database BIOMD0000000189

isDescribedBy (1 statement)
PubMed 20181016

hasTaxon (1 statement)
Taxonomy Mammalia

isVersionOf (2 statements)
hasProperty (1 statement)
Human Disease Ontology Alzheimer's disease

isPartOf (1 statement)
KEGG Pathway Alzheimer's disease


Curation status
Curated


Connected external resources